Product Details
| Product Name: Budesonide | CAS No.: 51333-22-3 |
| EC-No.: 257-139-7 | Min. Order: 10G |
| Purity: 99%min | Supply Ability: 100kg/week |
| Release date: 2019/01/15 |
Top 99% Active Pharmaceutical Ingredients Budesonide CAS 51333-22-3 For Treatment Asthma Disease
Budesonide------Basic Information:
| Product Name | Budesonide |
| Synonyms | PREFERID;PULMICORT;SPIROCORT;S-1320;RHINOCORT;BIDIEN;BUDESONIDE;CORTIVENT |
| CAS NO | 51333-22-3 |
| Einecs No | 246-634-3 |
| MF | C25H34O6 |
| MW | 430.53 |
| EINECS: | 257-139-7 |
| Purity | >99% |
| Packing | Galvanied iron barrel,net weight:200kg±0.05 |
| Storage temp | -20°C Freezer |
| Chemical Properties | White Solid |
| Product Categories | Pharmaceutical Intermediates;Heterocycles;Miscellaneous Reagents |
| Lead time | Within 24 hours upon receipt of payment |
| Shipment | EMS, DHL, TNT, FedEx, UPS |
| Uses | A non-halogenated glucocorticoid related to triamcinolone hexacetonide. Used as an antiinflammatory agent |
| Product Categories | Organics;Intermediates & Fine Chemicals;Pharmaceuticals;Steroids;Pharmaceutical intermediate;TORADOL;Hormone Drugs |
Budesonide------Medical uses
- Asthma
Budesonide is nebulized for maintenance and prophylactic treatment of asthma including patients who require oral corticosteroids and those who may benefit from a systemic dose reduction.
- Inflammatory bowel disease
Budesonide,Formulations of delayed-release Budesonide can be effective treatment for mild-to-moderately active Crohn's disease involving the ileum and/or ascending colon.A Cochrane review found evidence for up to 3 months (but not longer) of maintenance of remission Crohn's disease.
Budesonide assists in the induction of remission in people with active ulcerative colitis.
- Allergic rhinitis
Budesonide,Nasal spray budesonide is a treatment for allergic rhinitis.
Budesonide------COA:
| Item | Specification | Result |
| Loss on Drying | Not more than 4.0% | 0.46% |
| Appearance | An odorless, almost white or buff colored powder | Pass |
| [a]20/D C=1 in 1M HCl/EtOH 1:4 | +18 ~ +22o | +20.9o |
| Assay(HPLC) | Not less than 95.0% | 99.58% |
| Levothyroxine sodium | Not more than 5.0% | 0.68% |
| Conclusion | Up to the Standard for Export. |
Company Profile Introduction
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
|
VIP6Y
|
RongNa Biotechnology Co.,Ltd
|
2026-06-06 | ||
|
VIP5Y
|
Changsha Staherb Natural Ingredients Co., Ltd.
|
2026-06-06 | ||
|
VIP5Y
|
Sinoway Industrial co., ltd.
|
2026-06-03 | ||
| $70.00 |
VIP3Y
|
Zibo Hangyu Biotechnology Development Co., Ltd
|
2026-05-05 | |
| $8.89 |
Hebei Chuanghai Biotechnology Co., Ltd
|
2026-03-20 | ||
| $50.00 |
Hebei Zhuanglai Chemical Trading Co Ltd
|
2025-05-23 | ||
| $120.00 |
Shandong Xuhuang New material CoLTD
|
2025-03-21 | ||
|
airuikechemical co., ltd.
|
2024-12-24 | |||
| $200.00 |
Hebei Mingeng Biotechnology Co., Ltd
|
2023-06-26 | ||
| $9.90 |
Shanghai Biolang Biotechnology Co., Ltd.
|
2022-02-23 |
China